Kintor Pharmaceutical Limited (KNTPF)
USD 0.18
(0.0%)
USD 0.18
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -1.06 Billion CNY | -13.25% |
| 2022 | -944.52 Million CNY | -12.5% |
| 2021 | -839.6 Million CNY | -66.31% |
| 2020 | -504.85 Million CNY | -120.76% |
| 2019 | -228.68 Million CNY | -118.89% |
| 2018 | -104.47 Million CNY | -126.69% |
| 2017 | -46.08 Million CNY | 21.77% |
| 2016 | -58.9 Million CNY | -333.27% |
| 2015 | -13.59 Million CNY | -40.02% |
| 2014 | -9.71 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -4588.32 USD | 100.0% |
| 2024 Q2 | -4558.71 USD | 0.65% |
| 2023 FY | -1.06 Billion CNY | -13.25% |
| 2023 Q3 | -58.4 Thousand USD | 99.82% |
| 2023 Q1 | -15.02 Thousand USD | 99.98% |
| 2023 Q2 | -32.38 Million USD | -215372.03% |
| 2023 Q4 | -117.94 Million USD | -201847.6% |
| 2022 Q4 | -63.68 Million USD | 0.0% |
| 2022 FY | -944.52 Million CNY | -12.5% |
| 2022 Q2 | -82.64 Million USD | 0.0% |
| 2021 Q4 | -79.73 Million USD | 0.0% |
| 2021 FY | -839.6 Million CNY | -66.31% |
| 2021 Q2 | -52.21 Million USD | 0.0% |
| 2020 Q4 | -32.09 Million USD | 0.0% |
| 2020 FY | -504.85 Million CNY | -120.76% |
| 2020 Q2 | -25.08 Million USD | 0.0% |
| 2019 Q2 | -14.93 Million USD | 0.0% |
| 2019 Q4 | -20.79 Million USD | 0.0% |
| 2019 FY | -228.68 Million CNY | -118.89% |
| 2018 FY | -104.47 Million CNY | -126.69% |
| 2017 FY | -46.08 Million CNY | 21.77% |
| 2016 FY | -58.9 Million CNY | -333.27% |
| 2015 FY | -13.59 Million CNY | -40.02% |
| 2014 FY | -9.71 Million CNY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Nuo Therapeutics, Inc. | -3.16 Million USD | -33662.074% |
| CNBX Pharmaceuticals Inc. | -931.38 Thousand USD | -114748.397% |
| Mosaic ImmunoEngineering Inc. | -2.62 Million USD | -40610.411% |
| Evofem Biosciences, Inc. | -17.84 Million USD | -5893.584% |
| GB Sciences, Inc. | -1.42 Million USD | -75202.233% |
| Inhibitor Therapeutics, Inc. | -3.4 Million USD | -31315.025% |
| NanoSphere Health Sciences Inc. | -220.07 Thousand USD | -485943.585% |
| Skye Bioscience, Inc. | -13.67 Million USD | -7723.951% |
| Zenith Capital Corp. | -8.94 Million USD | -11861.031% |
| Agentix Corp. | -1.37 Million USD | -77878.518% |
| Arch Therapeutics, Inc. | -5.04 Million USD | -21104.849% |
| Biomind Labs Inc. | -1 Million USD | -105850.062% |
| ContraFect Corporation | -56.88 Million USD | -1780.284% |
| CSL Limited | 3.7 Billion USD | 128.895% |
| CytoDyn Inc. | -18.05 Million USD | -5823.552% |
| GlobeStar Therapeutics Corporation | -1.86 Million USD | -57274.609% |
| Neon Bloom, Inc. | -389.57 Thousand USD | -274478.381% |
| Northwest Biotherapeutics, Inc. | -55.5 Million USD | -1827.065% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -257355.852% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -69538.078% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -155613.662% |
| Santhera Pharmaceuticals Holding AG | 81.85 Million USD | 1406.842% |
| SQZ Biotechnologies Company | -75.82 Million USD | -1310.715% |
| Therapeutic Solutions International, Inc. | -1.98 Million USD | -53747.788% |
| Eiger BioPharmaceuticals, Inc. | -71.78 Million USD | -1390.089% |
| Intellipharmaceutics International Inc. | -2.85 Million USD | -37425.781% |
| Mesoblast Limited | -84.14 Million USD | -1171.198% |
| Marizyme, Inc. | -34.08 Million USD | -3038.118% |
| Genus plc | 6.4 Million USD | 16813.672% |
| Pharming Group N.V. | -4.87 Million USD | -21821.618% |
| Nymox Pharmaceutical Corporation | -8.35 Million USD | -12710.479% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -76196.852% |
| IMV Inc. | -38.67 Million USD | -2666.054% |
| AXIM Biotechnologies, Inc. | -2.75 Million USD | -38785.409% |
| MultiCell Technologies, Inc. | -722.81 USD | -147988306.359% |
| ONE Bio Corp. | 13.68 Million USD | 7918.376% |
| RVL Pharmaceuticals plc | -58.99 Million USD | -1713.316% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| Emmaus Life Sciences, Inc. | 3.54 Million USD | 30316.808% |
| Provectus Biopharmaceuticals, Inc. | -2.9 Million USD | -36769.453% |
| Oncotelic Therapeutics, Inc. | -6.64 Million USD | -15990.141% |
| THC Farmaceuticals, Inc. | -29.95 Thousand USD | -3571197.409% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | -6640.345% |
| Alpha Cognition Inc. | -9.7 Million USD | -10921.213% |
| Enzolytics Inc. | -2.14 Million USD | -49680.11% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -425.04 Million USD | -151.659% |
| Enzon Pharmaceuticals, Inc. | -1.04 Million USD | -102359.291% |
| Endonovo Therapeutics, Inc. | -2.91 Million USD | -36539.682% |
| Genscript Biotech Corporation | -415.79 Million USD | -157.263% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | 21864.316% |
| Institute of Biomedical Research Corp. | -261.72 Thousand USD | -408600.32% |
| Sigyn Therapeutics, Inc. | -2.45 Million USD | -43465.658% |
| WPD Pharmaceuticals Inc. | -171.5 Thousand USD | -623582.508% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -53256.841% |
| VioQuest Pharmaceuticals, Inc. | 9.74 Million USD | 11079.518% |
| PsyBio Therapeutics Corp. | -4.55 Million USD | -23384.947% |
| Adynxx, Inc. | - USD | Infinity% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| Accustem Sciences Inc. | -3.74 Million USD | -28451.932% |
| Helix BioMedix, Inc. | -984.05 Thousand USD | -108600.954% |
| EV Biologics, Inc. | -483.06 Thousand USD | -221336.379% |
| Q BioMed Inc. | -3.44 Million USD | -30944.522% |
| Capstone Therapeutics Corp. | -1.25 Million USD | -85065.207% |
| American Oriental Bioengineering, Inc. | -54.97 Million USD | -1845.842% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| BioStem Technologies, Inc. | -7.77 Million USD | -13650.858% |
| Curative Biotechnology, Inc. | -1.93 Million USD | -55248.725% |
| HST Global, Inc. | -140.9 Thousand USD | -759035.458% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -79999.608% |
| Wesana Health Holdings Inc. | -1.12 Million USD | -94990.168% |
| Halberd Corporation | -75.05 Thousand USD | -1425183.145% |
| Resverlogix Corp. | -12.74 Million USD | -8290.266% |
| Cell Source, Inc. | -4.32 Million USD | -24630.392% |
| RespireRx Pharmaceuticals Inc. | -1.57 Million USD | -67628.598% |
| GeneThera, Inc. | - USD | Infinity% |
| AVAX Technologies, Inc. | 6.69 Million USD | 16082.283% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -6140046.949% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| NovAccess Global Inc. | -2.46 Million USD | -43263.562% |
| Kadimastem Ltd | -3.04 Million USD | -35083.784% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Rasna Therapeutics, Inc. | -4.23 Million USD | -25137.624% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -181.48 Thousand USD | -589301.328% |
| LadRx Corporation | -3.82 Million USD | -27875.409% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -155613.662% |
| Affymax, Inc. | -15.04 Million USD | -7009.365% |
| Itoco Inc. | -919.14 Thousand USD | -116277.81% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -95492.046% |
| Mobile Lads Corp. | -554.55 Thousand USD | -192790.632% |
| International Stem Cell Corporation | -663 Thousand USD | -161238.612% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| Bioxytran, Inc. | -3.82 Million USD | -27900.886% |
| NDT Pharmaceuticals Inc. | -25.17 Thousand USD | -4249701.351% |
| Qrons Inc. | -643.67 Thousand USD | -166081.952% |
| Alseres Pharmaceuticals, Inc. | -564.72 Thousand USD | -189315.873% |
| SYBLEU INC | -149.18 Thousand USD | -716936.466% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -2.22 Million USD | -47870.092% |
| Rebus Holdings, Inc. | -664 Thousand USD | -160995.633% |
| ImmunoCellular Therapeutics, Ltd. | -1.81 Million USD | -58792.431% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -2031957.371% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -20.34 Thousand USD | -5258872.468% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -36.26 Million USD | -2849.526% |
| Adhera Therapeutics, Inc. | -1.61 Million USD | -66010.939% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -735.83 Thousand USD | -145268.867% |
| Innovation Pharmaceuticals Inc. | -3.11 Million USD | -34283.639% |
| Neutra Corp. | -229.48 Thousand USD | -466017.759% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -5998.837% |
| PureTech Health plc | -146.19 Million USD | -631.657% |
| Coeptis Therapeutics, Inc. | -21.49 Million USD | -4877.288% |
| IXICO plc | -1.43 Million USD | -74338.065% |
| IntelGenx Technologies Corp. | -9.49 Million USD | -11170.414% |
| Gelesis Holdings, Inc. | -121.8 Million USD | -778.179% |
| CSL Limited | 3.81 Billion USD | 128.061% |
| Cellectis S.A. | -108.85 Million USD | -882.639% |